Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded down 21.4% during trading on Thursday. The stock traded as low as GBX 0.90 and last traded at GBX 1.10. 12,103,827 shares were traded during mid-day trading, an increase of 567% from the average session volume of 1,813,663 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Price Performance
The firm’s fifty day moving average is GBX 1.56 and its two-hundred day moving average is GBX 2.19. The firm has a market capitalization of £4.67 million, a PE ratio of -6.88 and a beta of 0.02.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its earnings results on Wednesday, September 30th. The company reported GBX (0.08) EPS for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
